A common-source outbreak of fulminant hepatitis B in a hospital. 1989

I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
Rambam Medical Center, Haifa, Israel.

A nosocomial outbreak of fulminant hepatitis B infection at a medical center in Haifa, Israel, between 7 and 26 June 1986, involved five patients who had been hospitalized previously in the medical ward in late April and early May (first generation). This outbreak had an unusual clinical course, with fulminant hepatic failure associated with acute renal failure from acute glomerulonephritis, leading to death within a few days. The onset dates of hepatitis were tightly clustered temporally and incubation periods were short. Extensive laboratory and epidemiologic evaluation showed that the probable common-source vehicle of transmission was a multiple-dose vial of heparin and normal saline flush solution that may have been contaminated by blood of a known HBsAg carrier, who was positive for anti-HBe, hospitalized at the same time. A sixth patient died in August 1986 (second generation), after his initial admission in June that coincided with the terminal hospitalizations of three first-generation patients. Those patients had marked coagulopathies, and transmission to the sixth patient most probably occurred through environmental contamination by patients or through cross-contamination between patients through staff. The unusually high mortality rate (5 of 6) in this outbreak has not been definitely explained.

UI MeSH Term Description Entries
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010564 Personnel, Hospital The individuals employed by the hospital. Hospital Personnel
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D004812 Epidemiologic Methods Research techniques that focus on study designs and data gathering methods in human and animal populations. Epidemiologic Method,Epidemiological Methods,Methods, Epidemiologic,Epidemiological Method,Method, Epidemiologic,Method, Epidemiological,Methods, Epidemiological
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
December 1995, Kidney international,
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
February 1998, Lancet (London, England),
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
August 2000, Journal of clinical microbiology,
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
July 1981, The New Zealand medical journal,
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
August 1994, Infection control and hospital epidemiology,
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
January 2003, Journal of gastroenterology,
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
May 1971, The Journal of the Kentucky Medical Association,
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
March 1982, The Journal of communicable diseases,
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
January 1966, American journal of epidemiology,
I Oren, and R C Hershow, and E Ben-Porath, and N Krivoy, and N Goldstein, and S Rishpon, and D Shouval, and S C Hadler, and M J Alter, and J E Maynard
April 1993, The Journal of infectious diseases,
Copied contents to your clipboard!